Concepedia

Author

Laure Montané

Centre Léon Bérard

Also Known As

L Montane, L Montané, L. Montane, L. Montané, Laure Montane, Laure Montané

19

Publications

366

Citations

7

H-Index

23

Concepts

All Affiliations

Centre Léon BérardUniversité Claude Bernard Lyon 1InsermUniversité Grenoble AlpesCentre Hospitalier Universitaire de Grenoble
LM

About

Laure Montané is an author at Centre Léon Bérard specializing in medicine, molecular oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

69

2

Pathology

2

2

56

3

Pharmacology

2

2

56

4

Immunology

1

1

45

5

Obstetrics

1

1

13

Laure Montané

×

6

Publications

327

Citations

6

H-Index

YearCitations

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Julien Mazières, Claire Cropet, Laure Montané,

Annals of Oncology

2020

185

MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).

Philippe A. Cassier, Gwenaëlle Garin, Lauriane Eberst,

Journal of Clinical Oncology

2019

45

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

Aurélien Voissière, Carlos Gomez‐Roca, Sylvie Chabaud,

Science Translational Medicine

2024

41

MEVITEM—a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation

Didier Frappaz, Marc Barritault, Laure Montané,

Neuro-Oncology

2021

32

LBA33 Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced high‐grade ovarian carcinoma (HGOC): Final analysis of second progression-free survival (PFS2) in the phase III PAOLA-1/ENGOT-ov25 trial

A. González Martín, Youssef Tazi, Florian Heitz,

Annals of Oncology

2020

13

OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.

Julien Mazières, Laure Montané, Fabrice Barlési,

Journal of Thoracic Oncology

2018

11

Page 1